What LC-MS adds to a sequencing result
Sequencing and mass spectrometry are asked to do the same job often enough that the difference gets lost. One reports positions; the other reports what is chemically in a sample. Read together they answer a question neither answers alone.
01What this article answers
A sequencing method for RNA modifications infers the presence of a mark from how the RNA behaves — how it converts, where a reverse transcriptase stalls or mispairs, where a fragment ends. That inference is anchored to a position in a transcript. LC-MS does something different: it separates and detects the nucleosides themselves, so what comes back is the chemical composition of the material that was put in.
The two answer different questions, and the useful part is knowing which one a given claim needs. This review covers what each reports, where an independent measurement earns its place, and where mass spectrometry cannot help.
02Positions against composition
The distinction is easiest to see in what each result looks like. A sequencing result is a list: transcript, position, level. A mass spectrometry result is a composition: which nucleosides are present in the material, and in what proportion.
| Sequencing | LC-MS | |
|---|---|---|
| What it reads | How the RNA behaves at a modified base | The nucleosides themselves, separated by mass |
| What the result is | A position, with a level at that position | A composition, over the RNA that was analyzed |
| What it can be compared with | Other samples run through the same workflow | Other preparations analyzed the same way |
| What it cannot give | Nothing about the mark beyond what the chemistry reports | A position, a transcript, or a site-level ratio |
The first row is where the two are most often confused. A sequencing workflow carries its own chemistry, and every chemistry has bases it reports well and bases it reports less well. Mass spectrometry carries a different assumption: that the nucleoside is separable and detectable. Where the two agree, a result has survived two unrelated routes to it.
That is the case the method is worth running for. A position called by sequencing, and the same modification measured in the same RNA by an independent physical method, is a stronger statement than a position called twice by two versions of the same chemistry.
03When the independent measurement is worth having
- The conclusion rests on one call. Where a single site or a single mark carries the argument, an independent check is what keeps the argument from resting on one workflow.
- Two sequencing routes were compared. Agreement between two chemistries that share the same underlying assumption is weaker evidence than it looks, and a physical measurement breaks the loop.
- A less familiar mark is involved. Where the detection chemistry for a mark is newer, an independent confirmation of what is in the sample is a sensible first check.
- The material is limited and precious. Mass spectrometry runs on a selected, isolated RNA rather than across the transcriptome, which makes it a way to check a specific fraction rather than to survey.
- The claim is about the total level of a mark. For a question about how much of a modified nucleoside is present in a defined RNA population, composition is the measurement being asked for.
- Positions are already known. Where the site list exists and the question is whether the same material contains the mark, the two methods fit together with little wasted work.
04Limits and common misreadings
- LC-MS does not replace sequencing. It reports no position, no transcript and no per-site ratio, so it cannot answer a site-level question however sensitive it is.
- It is not a screen. The analysis runs on a selected, isolated RNA, which is its defined scope; a transcriptome-wide survey is a sequencing question.
- Agreement is not identity. Two methods that agree on the presence of a mark have both measured something, and the composition result is the one that does not depend on the conversion chemistry of the other.
- “Gold standard” overstates it. Mass spectrometry is an independent method with its own sample requirements and its own handling; describing it as the reference against which everything else is judged reads more into it than the technique supports.
- A composition shift is not a mechanism. A change in the proportion of a modified nucleoside says what is in the sample. Which enzyme put it there, and what it does to the transcript, are separate experiments.
06FAQ
If LC-MS cannot give positions, why run it at all?
Because the argument for a position usually rests on a method that infers it. An independent measurement of what is chemically present in the same material is a different kind of evidence, and it is the reason the method is used as a check rather than as a survey.
Can the two results be compared numerically?
Not directly. One is a level at a position and the other a proportion over a preparation, so they are read as consistent or not consistent rather than as two versions of the same number. Where the sequencing result is a ratio at a site, there is no arithmetic that turns one into the other.
What kind of material does the composition measurement need?
A selected, isolated RNA. That requirement is what defines the technique's scope here, and it is the practical difference from a sequencing run on total RNA. It is also why the measurement is a check on a defined fraction rather than a way to survey a transcriptome.
Does a positive composition result mean the site list is correct?
It means the mark is present in the material, which is a statement about composition rather than about position. Whether it sits at the reported positions is still a question for the methods that resolve positions, so the two results are read as consistent rather than as one confirming the other.